Investment Rating - The report initiates coverage with a "Buy" rating for Shuiyang Co., Ltd. [3][13] Core Insights - The cosmetics and medical beauty sector underperformed the market, with the Shenwan Beauty Care Index increasing by 0.2% from September 5 to September 12, 2025, lagging behind the Shenwan A Index by 2.7 percentage points [3][4] - Domestic cosmetics brands showed strong growth in August, with key brands under Shumei Co. achieving a 70% growth rate on Douyin and Taobao platforms, indicating a robust performance despite high base effects [3][9] - The report highlights the upcoming Double 11 shopping festival, suggesting that brands should prepare for promotional strategies [3][9] Summary by Sections Industry Performance - The cosmetics and medical beauty sector's performance was weaker than the market, with declines in the Shenwan Cosmetics Index by 0.5% and the Shenwan Personal Care Index by 0.8% during the specified period [3][4] Key Company Review - Shuiyang Co., Ltd. is positioned as a leading technology-driven beauty company in China, with stable revenue between 4 to 5 billion yuan from 2021 to 2024 and an expected gross margin of 63.01% in 2024, up by 10.94 percentage points from 2021 [3][10] - The company has a dual business model of proprietary brands and CP agency brands, with a strong focus on high-end and global market transformation [3][10][12] E-commerce Data - In August, key domestic brands on Douyin and Taobao platforms showed significant growth, with Shumei Co. brands achieving a 70% increase, and other brands like Maogeping and Runben also reporting substantial growth rates [3][14] Market Trends - The report notes that the overall retail sales of cosmetics in July 2025 grew by 4.5%, indicating a recovery in consumer spending [3][17] - The domestic skincare market is projected to reach 271.2 billion yuan in 2024, despite a slight decline of 3.7% year-on-year, with domestic brands gaining market share [3][26] Company Announcements - Shumei Co. has appointed Dr. Karl Lintner, a pioneer in peptide beauty, as the chief scientific advisor, aiming to enhance its global competitiveness in research and development [3][21]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Views - The report highlights the launch of the "Gaode Street Ranking," which aims to reconstruct the trust framework in offline services through real navigation and travel behavior data [23][27] - The report emphasizes the importance of emotional consumption themes and suggests focusing on high-quality companies in high-growth sectors [6][29] Summary by Sections Retail Market Review - The retail industry index closed at 2396.85 points, up 0.85% for the week, underperforming the Shanghai Composite Index, which rose by 1.52% [12][20] - Among retail sub-sectors, the supermarket sector had the highest weekly increase of 4.78%, while the watch and jewelry sector led with a year-to-date increase of 35.68% [14][18] Industry Dynamics - The launch of the "Gaode Street Ranking" is positioned as a significant step for Alibaba to transition from a navigation platform to a comprehensive local service platform, enhancing user experience and trust [23][27] - The ranking system incorporates real user behavior and credit filtering to provide authentic feedback, potentially disrupting the existing "to-store" business landscape dominated by Meituan and Dianping [27][29] Investment Recommendations - Investment Theme 1: Focus on differentiated gold and jewelry brands with deep consumer insights, recommending companies like Laopu Gold and Chaohongji [6][31] - Investment Theme 2: Highlight retail enterprises that adapt to trends and actively explore changes, recommending Yonghui Supermarket and Aiyingshi [6][29] - Investment Theme 3: Emphasize high-quality domestic beauty brands with differentiated capabilities, recommending brands like Maogeping and Pola [6][30] - Investment Theme 4: Focus on differentiated medical beauty product manufacturers, recommending Aimeike and Kedi-B [6][30] Company Performance Highlights - Laopu Gold reported a revenue of 12.354 billion yuan in H1 2025, a year-on-year increase of 250.9%, with a net profit of 2.268 billion yuan, up 285.8% [38][39] - Chaohongji achieved a revenue of 4.102 billion yuan in H1 2025, a 19.5% increase, with a net profit of 331 million yuan, up 44.3% [41][42] - Maogeping reported a revenue of 2.588 billion yuan in H1 2025, a 31.3% increase, with a net profit of 670 million yuan, up 36.1% [31][34]

Market Overview - The personal care products sector experienced a decline of 1.1% on September 12, with Baiya Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 3883.69, up 0.22%, while the Shenzhen Component Index closed at 12996.38, up 0.13% [1] Stock Performance - Key stocks in the personal care sector showed varied performance, with Jeya Co., Ltd. increasing by 5.01% to a closing price of 34.18 [1] - Other notable movements include: - Yiyi Co., Ltd. up 0.53% to 28.40 - Runben Co., Ltd. down 0.41% to 28.82 - Reliable Co., Ltd. down 0.64% to 13.87 [1][2] Trading Volume and Value - The trading volume and value for selected stocks are as follows: - Jeya Co., Ltd.: 36,300 shares, 123 million yuan - Yiyi Co., Ltd.: 60,500 shares, 175 million yuan - Runben Co., Ltd.: 15,900 shares, 46.01 million yuan [1] Capital Flow Analysis - The personal care products sector saw a net outflow of 24.69 million yuan from institutional investors and 8.31 million yuan from speculative funds, while retail investors had a net inflow of 33 million yuan [2] - Detailed capital flow for selected stocks indicates: - Zhongshun Jierou: 12.26 million yuan net inflow from institutions - Yiyi Co., Ltd.: 6.18 million yuan net inflow from institutions [3] Summary of Individual Stocks - Zhongshun Jierou had a net institutional inflow of 12.26 million yuan, but a net outflow from speculative and retail investors [3] - Reliable Co., Ltd. showed mixed results with a small net inflow from speculative funds but a net outflow from retail investors [3] - Overall, the sector's performance reflects a cautious sentiment among institutional and speculative investors, while retail investors appear to be more active [2][3]

Core Viewpoint - The company reported a revenue of 895 million yuan for the first half of 2025, reflecting a year-on-year growth of 20.3%, while the net profit attributable to shareholders was 188 million yuan, up 4.2% year-on-year [1] Revenue and Profit Analysis - In Q2 2025, the company achieved a revenue of 655 million yuan, representing a year-on-year increase of 13.5%, but the net profit attributable to shareholders decreased by 0.8% to 143 million yuan [1] - The company's net profit margin declined by 3.2 percentage points in H1 2025, primarily due to a 0.6 percentage point drop in gross margin and a 1.5 percentage point increase in sales expense ratio [3] Product Category Performance - In H1 2025, sales for mosquito repellent, baby care, and essential oils were 375 million, 405 million, and 92 million yuan respectively, with year-on-year changes of +13%, +39%, and -15% [2] - In Q2, mosquito repellent and baby care products grew by 14% and 23% respectively, while essential oils saw a decline of 16% [2] Channel Expansion - The company has strengthened its online channel presence while expanding offline channels, maintaining a high market share on platforms like Tmall, JD, and Douyin, and has initiated cooperation with Sam's Club [2] - The company has developed non-platform distribution channels, including partnerships with major retailers such as Yonghui and Walmart, which is expected to further solidify brand sales [2] Investment Outlook - The company continues to innovate its product offerings and faces temporary profit pressure due to increased promotional expenses [3] - The expected EPS for 2025-2027 is projected to be 0.82, 1.04, and 1.30 yuan per share, maintaining a "buy" rating [3]

Core Viewpoint - The company announced a cash dividend distribution of 0.20 CNY per share for the first half of 2025, approved by the shareholders' meeting on September 3, 2025 [2][4]. Dividend Distribution Details - The total cash dividend distribution amounts to 80,918,662.80 CNY, based on a total share capital of 404,593,314 shares [4]. - The distribution is applicable to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the day before the dividend record date [3]. Implementation Method - The cash dividends will be distributed through the clearing system of the China Securities Depository and Clearing Corporation Limited, with shareholders able to receive their dividends at their designated securities firms on the payment date [5]. - For shareholders who have not completed designated trading, the dividends will be held by the China Securities Depository and Clearing Corporation Limited until the designated trading is completed [5]. Taxation Information - For individual shareholders holding shares for over one year, the cash dividend of 0.20 CNY per share is exempt from personal income tax [9]. - For shares held for one year or less, the tax will be calculated upon the transfer of shares, with the actual cash dividend remaining at 0.20 CNY per share [9]. - For foreign institutional investors (QFII), a 10% withholding tax applies, resulting in a net cash dividend of 0.18 CNY per share [11]. Related Dates and Conditions - The dividend distribution is not associated with any differential dividend or capital increase [7]. - The announcement includes commitments from major shareholders regarding the minimum selling price of shares post-dividend distribution [12]. Contact Information - Shareholders can inquire about the dividend distribution through the company's securities department at the provided contact number [13].

Group 1 - The company, Runben Co., announced a cash dividend distribution plan for the first half of 2025, with a cash dividend of 0.20 yuan per share (tax included) for A-shares [2] - The record date for the dividend is set for September 17, 2025, while the ex-dividend date and the date of cash dividend payment are both scheduled for September 18, 2025 [2]

证券代码：603193 证券简称：润本股份 公告编号：2025-038 润本生物技术股份有限公司 2025年半年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利0.20元（含税） 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/9/17 | － | 2025/9/18 | 2025/9/18 | 差异化分红送转： 否 一、 通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 9 月 3 日的2025年第二次临时股东会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本404,593,314股为基数，向全体股东每股派发现 金红利0.20元（ ...

Market Overview - The personal care products sector increased by 0.76% on September 11, with Yanjiang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3875.31, up 1.65%, while the Shenzhen Component Index closed at 12979.89, up 3.36% [1] Stock Performance - Yanjiang Co., Ltd. (300658) closed at 8.61, with a rise of 6.82% and a trading volume of 412,000 shares, amounting to a transaction value of 353 million yuan [1] - Yiyi Co., Ltd. (001206) closed at 28.25, up 4.28%, with a trading volume of 77,700 shares and a transaction value of 215 million yuan [1] - Beijia Co., Ltd. (603059) closed at 32.58, up 2.45%, with a trading volume of 62,400 shares and a transaction value of 203 million yuan [1] - Other notable performances include Reliable Co., Ltd. (301009) at 13.96 (+1.82%), and Zhongshun Jiesang (002511) at 8.58 (+1.06%) [1] Capital Flow Analysis - The personal care products sector experienced a net outflow of 43.97 million yuan from institutional investors and 22.16 million yuan from speculative funds, while retail investors saw a net inflow of 66.14 million yuan [2] - The detailed capital flow for individual stocks shows that Yiyi Co., Ltd. had a net inflow of 11.10 million yuan from institutional investors, while Reliable Co., Ltd. had a net inflow of 4.75 million yuan [3] - Conversely, companies like Two-Sided Needle (600249) and Dengkang Oral Care (001328) experienced significant net outflows from institutional and speculative funds [3]

Market Overview - The personal care products sector experienced a decline of 0.39% on September 10, with Dengkang Oral Care leading the drop [1] - The Shanghai Composite Index closed at 3812.22, up 0.13%, while the Shenzhen Component Index closed at 12557.68, up 0.38% [1] Stock Performance - Notable stock performances include: - Yanjing Co. (300658) rose by 7.47% to a closing price of 8.06, with a trading volume of 506,100 shares and a turnover of 412 million [1] - Jieya Co. (301108) increased by 2.01% to 32.98, with a trading volume of 25,700 shares and a turnover of 83.7 million [1] - Liangmian Needle (600249) saw a rise of 1.21% to 6.69, with a trading volume of 1,118,000 shares and a turnover of 745 million [1] - Dengkang Oral Care (001328) fell by 2.24% to 40.62, with a trading volume of 17,500 shares and a turnover of 71.3 million [2] Capital Flow - The personal care products sector saw a net outflow of 18.51 million from institutional investors, while retail investors contributed a net inflow of 33.14 million [2] - The capital flow for key stocks includes: - Liangmian Needle had a net inflow of 22.12 million from institutional investors, but a net outflow of 16.05 million from retail investors [3] - Yanjing Co. experienced a net inflow of 3.64 million from institutional investors and a net outflow of 14.09 million from retail investors [3] - Dengkang Oral Care had a net outflow of 1.05 million from institutional investors and a net outflow of 2.16 million from retail investors [3]

Core Viewpoint - The company reported a stable performance in the first half of 2025, with significant growth in the baby care segment and effective product expansion strategies [1][2][3]. Financial Performance - In H1 2025, the company achieved revenue of 895 million yuan, net profit attributable to shareholders of 188 million yuan, and net profit excluding non-recurring items of 177 million yuan, representing year-on-year growth of 20.31%, 4.16%, and 0.86% respectively [1]. - In Q2 2025, the company recorded revenue of 655 million yuan, net profit attributable to shareholders of 143 million yuan, and net profit excluding non-recurring items of 138 million yuan, with year-on-year changes of +13.46%, -0.85%, and -3.94% respectively [1]. Product Performance - The company’s product categories showed varied performance: mosquito repellent products generated 375 million yuan in revenue (+13.4% YoY), baby care products reached 405 million yuan (+38.7% YoY), while essential oils saw a decline to 92 million yuan (-14.6% YoY) [2]. - The company maintained a strong market share across major e-commerce platforms and expanded offline channels, including a new partnership with Sam's Club, leading to rapid growth in non-platform distribution [2]. Profitability and Cost Structure - The company’s gross margin stood at 58.0%, a decrease of 0.6 percentage points year-on-year. The sales, management, R&D, and financial expense ratios were 30.3%, 1.81%, 1.83%, and -0.4% respectively, with year-on-year changes of +1.5, -0.1, -0.2, and +2.4 percentage points [2]. - The decline in net profit margin to 20.9% represented a year-on-year decrease of 3.2 percentage points, attributed to increased marketing expenditures and changes in channel structure [2]. Strategic Initiatives - The company continues to enhance its product matrix, launching over 40 new or upgraded products in H1 2025, while focusing on core categories like baby care and mosquito repellent, and entering new segments such as children's sunscreen and youth skincare [3]. - Significant capital investments are being made in the "Runben Biotechnology R&D Production Base Project" and the "Runben Intelligent Manufacturing Future Factory Project," strengthening the integrated R&D and production capabilities for long-term growth [3]. Investment Outlook - As a leading player in the domestic mosquito repellent and baby care sectors, the company is expected to benefit from its strong brand recognition and integrated model, which creates a competitive edge [3]. - Despite short-term pressure on profit margins due to increased marketing investments, the company’s multi-category and all-channel strategy is anticipated to enhance market share and provide clear growth pathways [3]. - The profit forecast for 2025-2027 has been slightly adjusted to 330 million yuan, 420 million yuan, and 530 million yuan respectively, with corresponding PE ratios of 37, 28, and 23 times [3].